Nervgen Pharma Ord Shs
NGEN5.750USD
-0.220-3.69%
Close 01/09, 16:00（ET）Quotes delayed by 15 min
--Market Cap
--P/E TTM
More Details of Company
Nervgen Pharma Ord Shs Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Nervgen Pharma Ord Shs
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Fri, Jan 9
Updated: Fri, Jan 9
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
PFP Biosciences Holdings LLC
18.45%
Punnett, Harold
1.48%
Bayley (Brian E)
0.71%
Kelly (Michael)
0.18%
Kaye (Randall E)
0.14%
Other
79.04%
Shareholders
Shareholders
Proportion
PFP Biosciences Holdings LLC
18.45%
Punnett, Harold
1.48%
Bayley (Brian E)
0.71%
Kelly (Michael)
0.18%
Kaye (Randall E)
0.14%
Other
79.04%
Shareholder Types
Shareholders
Proportion
Other Insider Investor
18.52%
Individual Investor
4.62%
Other
76.85%
Institutional Shareholding
Updated: Fri, Jan 9
Updated: Fri, Jan 9
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
2
--
0.00%
-47.80K
2025Q4
2
--
0.00%
-47.80K
2025Q3
2
--
0.00%
-47.80K
2025Q2
2
--
0.00%
-47.80K
2025Q1
2
--
0.00%
-47.80K
2024Q4
2
--
0.00%
-47.80K
2024Q3
2
--
0.00%
-47.80K
2024Q2
3
44.40K
0.06%
-41.20K
2024Q1
2
3.40K
0.01%
-30.00K
2023Q4
2
3.40K
0.01%
-30.00K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
PFP Biosciences Holdings LLC
14.69M
18.45%
+1.81M
+14.05%
Nov 19, 2025
Punnett, Harold
1.18M
1.48%
+50.00K
+4.44%
Jul 18, 2025
Bayley (Brian E)
565.00K
0.71%
+250.00K
+79.37%
Nov 19, 2025
Kelly (Michael)
143.96K
0.18%
--
--
Mar 28, 2025
Kaye (Randall E)
110.00K
0.14%
+100.00K
+1000.00%
Dec 09, 2025
Mckerracher (Krista L)
109.76K
0.14%
+100.00K
+1024.80%
Dec 04, 2025
Ruffolo (John)
70.41K
0.09%
--
--
Mar 28, 2025
Ives (Glenn Antony)
58.51K
0.07%
--
--
Mar 28, 2025
Rogers (Adam)
20.00K
0.03%
+10.00K
+100.00%
May 16, 2025
Mikol (Daniel D. M.D., Ph.D)
5.00K
0.01%
+5.00K
--
May 20, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Nervgen Pharma Ord Shs?
The top five shareholders of Nervgen Pharma Ord Shs are:
PFP Biosciences Holdings LLC holds 14.69M shares, accounting for 18.45% of the total shares.
Punnett, Harold holds 1.18M shares, accounting for 1.48% of the total shares.
Bayley (Brian E) holds 565.00K shares, accounting for 0.71% of the total shares.
Kelly (Michael) holds 143.96K shares, accounting for 0.18% of the total shares.
Kaye (Randall E) holds 110.00K shares, accounting for 0.14% of the total shares.
PFP Biosciences Holdings LLC holds 14.69M shares, accounting for 18.45% of the total shares.
Punnett, Harold holds 1.18M shares, accounting for 1.48% of the total shares.
Bayley (Brian E) holds 565.00K shares, accounting for 0.71% of the total shares.
Kelly (Michael) holds 143.96K shares, accounting for 0.18% of the total shares.
Kaye (Randall E) holds 110.00K shares, accounting for 0.14% of the total shares.
What are the top three shareholder types of Nervgen Pharma Ord Shs?
The top three shareholder types of Nervgen Pharma Ord Shs are:
PFP Biosciences Holdings LLC
Punnett, Harold
Bayley (Brian E)
PFP Biosciences Holdings LLC
Punnett, Harold
Bayley (Brian E)
How many institutions hold shares of Nervgen Pharma Ord Shs (NGEN)?
As of 2026Q1, 2 institutions hold shares of Nervgen Pharma Ord Shs, with a combined market value of approximately --, accounting for --% of the total shares. Compared to 2025Q4, institutional shareholding has increased by --.
What is the biggest source of revenue for Nervgen Pharma Ord Shs?
In --, the -- business generated the highest revenue for Nervgen Pharma Ord Shs, amounting to -- and accounting for --% of total revenue.
